Brijesh Sutariya
Overview
Explore the profile of Brijesh Sutariya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morais A, Imai T, Jin X, Locascio J, Boisserand L, Herman A, et al.
Circ Res
. 2024 Jul;
135(5):575-592.
PMID: 39034919
Background: The SPAN trial (Stroke Preclinical Assessment Network) is the largest preclinical study testing acute stroke interventions in experimental focal cerebral ischemia using endovascular filament middle cerebral artery occlusion (MCAo)....
2.
Lyden P, Diniz M, Bosetti F, Lamb J, Nagarkatti K, Rogatko A, et al.
Sci Transl Med
. 2023 Sep;
15(714):eadg8656.
PMID: 37729432
Human diseases may be modeled in animals to allow preclinical assessment of putative new clinical interventions. Recent, highly publicized failures of large clinical trials called into question the rigor, design,...
3.
Patel R, Dhanesha N, Sutariya B, Ghatge M, Doddapattar P, Barbhuyan T, et al.
Stroke
. 2023 Jul;
54(9):2409-2419.
PMID: 37449422
Background: Obesity-induced hyperglycemia is a significant risk factor for stroke. Integrin α9β1 is expressed on neutrophils and stabilizes adhesion to the endothelium via ligands, including Fn-EDA (fibronectin containing extra domain...
4.
Tsai J, Gori S, Alt J, Tiwari S, Iyer J, Talwar R, et al.
PNAS Nexus
. 2023 Jan;
2(1):pgac297.
PMID: 36712931
Alopecia areata is a chronic hair loss disorder that involves autoimmune disruption of hair follicles by CD8 T cells. Most patients present with patchy hair loss on the scalp that...
5.
Jain M, Joharapurkar A, Patel V, Kshirsagar S, Sutariya B, Patel M, et al.
Eur J Pharmacol
. 2018 Nov;
843:113-120.
PMID: 30458168
Chronic inflammatory diseases are often associated with anemia. In such conditions, anemia is generally treated with erythropoiesis stimulating agents (ESAs) which are associated with potentially hazardous side effects and poor...
6.
Patel V, Joharapurkar A, Kshirsagar S, Patel M, Sutariya B, Patel H, et al.
Can J Physiol Pharmacol
. 2018 Feb;
96(6):587-596.
PMID: 29406832
Nonalcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 diabetes. Coagonists of glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR) are under clinical investigation for the...
7.
Patel V, Joharapurkar A, Kshirsagar S, Sutariya B, Patel M, Patel H, et al.
Cardiovasc Hematol Agents Med Chem
. 2018 Jan;
16(1):35-43.
PMID: 29357809
Background: Obesity, diabetes and dyslipidemica are the key pathogenic stimulus that enhances progression of Non-Alcoholic Fatty Liver Disease (NAFLD). Coagonist of Glucagon Like- Peptide-1 (GLP-1) Receptor (GLP-1R) and Glucagon Receptor...
8.
Patel V, Joharapurkar A, Kshirsagar S, Sutariya B, Patel M, Pandey D, et al.
Chem Biol Interact
. 2018 Jan;
282:13-21.
PMID: 29325849
Dyslipidemia enhances progression of atherosclerosis. Coagonist of GLP-1 and glucagon are under clinical investigation for the treatment of obesity and diabetes. Earlier, we have observed that coagonist reduced circulating and...
9.
Patel V, Joharapurkar A, Kshirsagar S, Sutariya B, Patel M, Patel H, et al.
Biomed Pharmacother
. 2017 Dec;
98:364-371.
PMID: 29275178
Coagonists of Glucagon-like peptide-1 (GLP-1) and glucagon receptors are under clinical investigation for treatment of obesity associated with diabetes. In addition to their role in glucose homeostasis, GLP-1 and glucagon...
10.
Sutariya B, Saraf M
Biomed Pharmacother
. 2017 Dec;
98:318-324.
PMID: 29274588
α-asarone is natural bioactive compound that has been reported to have many benefits and medicinal properties. The present study aimed to assess the protective effect of α-asarone against doxorubicin (DOX)...